Heparin in hypertriglyceridemia: Friend or foe?

Journal of Laboratory and Clinical Medicine

Volumn 138, Issue 6, 2001, Pages 356-358

  Ng, Dominic ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HEPARIN, LOW MOLECULAR WEIGHT; LOW MOLECULAR WEIGHT HEPARIN;

HUMAN; HYPERTRIGLYCERIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; NOTE; THROMBOEMBOLISM;

ANTICOAGULANTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMAN; HYPERTRIGLYCERIDEMIA; INFUSIONS, INTRAVENOUS; THROMBOEMBOLISM;

EID: 0035543340     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.119433     Document Type: Article

References (11)

1. The thromboplastic action of cephalin
2. Guide to anticoagulant therapy: Heparin
3. Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis
4. Successful outcome in severe pregnancy-associated hyperlipemia: A case report and literature review
5. Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation
6. Lipoprotein lipase during continuous heparin infusion: Tissue stores become partially depleted
7. Low-molecular-weight heparins in the treatment of acute coronary syndromes
8. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: A meta-analysis
9. Low molecular weight and unfractionated heparin in thrombosis prophylaxis: Meta-analysis based on original patient data
10. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events Study Group
11. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) IIB Trial